CoreWeave (CRWV) officer disposes shares via Rule 10b5-1; weighted-average prices shown
Rhea-AI Filing Summary
CoreWeave insider sale summary: The filing shows that McBee Brannin, Chief Development Officer of CoreWeave, Inc. (CRWV), sold multiple blocks of Class A common stock on 08/19/2025 under a Rule 10b5-1 trading plan adopted May 20, 2025. The transactions list a series of dispositions at weighted-average prices ranging from about $88.67 to $95.63 per share. Following these sales, the reporting person and related trusts hold varying remaining positions, with some trust-held lots reduced to zero. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Positive
- Sales executed under a Rule 10b5-1 trading plan, indicating preplanned transactions and providing affirmative defense language
- Detailed footnotes disclose weighted-average prices and price ranges, improving transparency
- Filing identifies related trusts and trustee relationships, clarifying indirect beneficial ownership
Negative
- Multiple sizable dispositions on a single date reduced the reporting person’s direct and trust-held Class A shares substantially
- Some trust-held positions were reduced to zero (Brannin J. McBee 2022 Irrevocable Trust shows a zero balance for one lot)
- No purchases reported to offset the sales in this filing
Insights
TL;DR: Multiple sizable sales executed through a 10b5-1 plan, reducing insider and related trust holdings.
The pattern shows systematic dispositions on a single date at a range of prices consistent with preplanned executions under Rule 10b5-1 adopted May 20, 2025. Weighted-average prices are disclosed for grouped lots with ranges provided in footnotes. No derivative transactions or purchases are reported. From an investor-information standpoint this is a transparency filing documenting liquidity events by an officer rather than an unplanned or opportunistic sale.
TL;DR: Transactions were covered by an affirmative-defense 10b5-1 plan, indicating planned insider sales rather than ad-hoc trading.
The filer disclosed that the sales were effected pursuant to a 10b5-1 plan, which generally reduces insider-trading concern by establishing pre-arranged terms. The filing also clarifies ownership through related irrevocable trusts and a minor child's record ownership, including trustee roles and powers. The form provides explanatory footnotes about price ranges and beneficial ownership allocation, supporting compliance and disclosure quality.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 19,746 | $89.3691 | $1.76M |
| Sale | Class A Common Stock | 46,088 | $90.1487 | $4.15M |
| Sale | Class A Common Stock | 41,894 | $91.1495 | $3.82M |
| Sale | Class A Common Stock | 91,240 | $92.3194 | $8.42M |
| Sale | Class A Common Stock | 38,129 | $92.8925 | $3.54M |
| Sale | Class A Common Stock | 6,680 | $94.07 | $628K |
| Sale | Class A Common Stock | 3,903 | $95.2545 | $372K |
| Sale | Class A Common Stock | 2,320 | $96.17 | $223K |
| Sale | Class A Common Stock | 29,620 | $89.3691 | $2.65M |
| Sale | Class A Common Stock | 69,131 | $90.1487 | $6.23M |
| Sale | Class A Common Stock | 62,840 | $91.1495 | $5.73M |
| Sale | Class A Common Stock | 136,861 | $92.3194 | $12.63M |
| Sale | Class A Common Stock | 57,193 | $92.8925 | $5.31M |
| Sale | Class A Common Stock | 10,020 | $94.07 | $943K |
| Sale | Class A Common Stock | 5,855 | $95.2544 | $558K |
| Sale | Class A Common Stock | 3,480 | $96.17 | $335K |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (11)
- F1. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.67 to $89.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 and in footnotes 3 through 8.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.67 to $90.66, inclusive.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.67 to $91.64, inclusive.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.68 to $92.675, inclusive.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.68 to $93.67, inclusive.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.71 to $94.68, inclusive.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.75 to $95.63, inclusive.
- F9. The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee.
- F10. The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.
- F11. The reported securities are directly held of record by the reporting person's minor child.
AI-generated analysis. How Rhea-AI works. Not financial advice.